Imunon, Inc. (IMNN) vs Processa Pharmaceuticals, Inc. (PCSA)
A side-by-side comparison of Imunon, Inc. and Processa Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMNN
Imunon, Inc.
$1.12HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PCSA
Processa Pharmaceuticals, Inc.
$1.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IMNN vs PCSA
growth of $100 · dividends reinvested · last 10yIMNN -100.0% (-55.2%/yr)PCSA -99.9% (-48.6%/yr)PCSA compounded faster over this window
IMNN PCSA
IMNN vs PCSA: by the numbers
- •IMNN is the larger company ($5M vs $4M market cap).
Metrics side by side
Valuation
| Metric | IMNN | PCSA |
|---|---|---|
| P/B ratio | 1.12 | N/A |
Profitability
| Metric | IMNN | PCSA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -351.30% | N/A |
| ROIC | -126.69% | N/A |
Growth (annualized)
| Metric | IMNN | PCSA |
|---|---|---|
| Total return CAGR (5Y) | -63.83% | -79.32% |
Frequently asked
- How have IMNN and PCSA total returns compared?
- Over the past 10 years, IMNN delivered -55.17% and PCSA delivered -48.59% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.